Company Overview of Horizon Pharma USA, Inc.
Horizon Pharma USA, Inc. is a biopharmaceutical company that develops prescription drugs for mild to moderate pain relief and arthritis. The company's products include HZT-501, a proprietary fixed dose combination formulation of NSAID and ibuprofen; and HZT-602, a combination oral drug product consisting of naproxen and famotidine. Horizon Pharma USA, Inc. was formerly known as Horizon Therapeutics, Inc. and changed its name to Horizon Pharma USA, Inc. in April 2010. The company was founded in 2005 and is based in Deerfield, Illinois. Horizon Pharma USA, Inc. operates as a subsidiary of Horizon Pharma plc.
520 Lake Cook Road
Deerfield, IL 60015
Founded in 2005
Key Executives for Horizon Pharma USA, Inc.
Horizon Pharma USA, Inc. Key Developments
Similar Private Companies By Industry
|Sabinsa Corporation||United States|
|Coria Laboratories, Ltd.||United States|
|OPKO Ophthalmics, LLC||United States|
|Pepgen Corporation||United States|
Recent Private Companies Transactions
July 7, 2015
March 30, 2015
|Hyperion Therapeutics, Inc.|
To contact Horizon Pharma USA, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.